Known as the 'man with the golden arm', James Harrison's blood contained a rare antibody that saved millions of lives.

Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.

Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...

At the booming biotech campus of Pegasus Park in Dallas, up-and-coming biopharmaceutical company GenrAb believes it’s onto ...

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

Sanghavi, R. , Tesmer, P. , Singh, D. and Sukumaran, S. (2025) Adolescent-Onset Triple-Antibody Positive Juvenile ...

The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...

The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

Summit Therapeutics shares are dropping Monday morning as it reported a fourth-quarter adjusted loss nearly double that of ...

Food-related allergies and their effects are insidiously common in the United States: over 7% of children and over 10% of ...

It was FDA approved based on a clinical trial that showed it, overall, delayed the onset of insulin dependence from two years ...

For National Protein Day, use this visual guide to ensure your meals have enough protein.